{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:44:36Z","timestamp":1792590276235,"version":"4.5.0"},"reference-count":17,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>This study describes the clinical and hematological characteristics of acute erythroblastopenia induced by Parvovirus B19 in patients with underlying hemoglobinopathies. We conducted a retrospective analysis of 53 patients with confirmed Parvovirus B19 infection, among whom 10 pediatric cases met the criteria for acute erythroblastopenia, defined by hemoglobin &lt;6 g\/dL and reticulocytopenia &lt;20x10^9\/L. Among 53 patients with confirmed Parvovirus B19 infection, 10 pediatric cases (18.9%) met the criteria for acute erythroblastopenia. All cases occurred in children with various hemoglobinopathies: sickle cell disease (3 cases), S\/beta-thalassemia (1 case), hemoglobin C disease (2 cases), and hereditary spherocytosis (2 cases), while two patients had no identified hemoglobinopathy. The mean hemoglobin was 5.13 \u00b1 1.66 g\/dL, with profound reticulocytopenia. Multi-lineage involvement occurred in 20% (n=2\/10) of cases. Bone marrow examination showed variable erythroblast percentages (1-47%). Recovery time ranged from 6 to 35 days, with the longest recovery observed in sickle cell patients. Parvovirus B19 causes severe erythroblastopenic crises in children with hemoglobinopathies, particularly in sickle cell disease, where the clinical impact is most pronounced.<\/jats:p>","DOI":"10.11604\/pamj.2026.54.2.49819","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:05:26Z","timestamp":1792587926000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute erythroblastopenia due to Parvovirus B19 in hemoglobinopathies: a retrospective case series at Ibn Sina Hospital, Rabat, Morocco"],"prefix":"10.11604","author":[{"given":"Ismail","family":"Regragui","sequence":"first","affiliation":[{"name":"Central Hematology Laboratory, Ibn Sina Hospital Center, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassane","family":"Mamad","sequence":"additional","affiliation":[{"name":"Central Hematology Laboratory, Ibn Sina Hospital Center, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalila","family":"Zirar","sequence":"additional","affiliation":[{"name":"Central Hematology Laboratory, Ibn Sina Hospital Center, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najoua","family":"El Mokhtari","sequence":"additional","affiliation":[{"name":"Central Hematology Laboratory, Ibn Sina Hospital Center, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ifleh","sequence":"additional","affiliation":[{"name":"Hematology Laboratory, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Benkirane","sequence":"additional","affiliation":[{"name":"Hematology Laboratory, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azlarab","family":"Masrar","sequence":"additional","affiliation":[{"name":"Hematology Laboratory, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002 Jul;15(3):485-505. PubMed | Google Scholar DOI: 10.1128\/CMR.15.3.485-505.2002","DOI":"10.1128\/CMR.15.3.485-505.2002"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Serjeant GR, Topley JM, Mason K, Serjeant BE, Pattison JR, Jones SE et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981 Sep 19;2(8247):595-7. PubMed | Google Scholar DOI: 10.1016\/S0140-6736(81)92739-2","DOI":"10.1016\/S0140-6736(81)92739-2"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Smith-Whitley K, Zhao H, Hodinka RL, Kwiatkowski J, Cecil R, Cecil T et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004 Jan 15;103(2):422-7. PubMed | Google Scholar. PubMed | Google Scholar DOI: 10.1182\/blood-2003-01-0069","DOI":"10.1182\/blood-2003-01-0069"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004 Feb 5;350(6):586-97. PubMed | Google Scholar DOI: 10.1056\/NEJMra030840","DOI":"10.1056\/NEJMra030840"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ganaie SS, Qiu J. Recent Advances in Replication and Infection of Human Parvovirus B19. Front Cell Infect Microbiol. 2018;8:166. PubMed | Google Scholar DOI: 10.3389\/fcimb.2018.00166","DOI":"10.3389\/fcimb.2018.00166"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Qiu J, S\u00f6derlund-Venermo M, Young NS. Human Parvoviruses. Clin Microbiol Rev. 2017 Jan;30(1):43-113. PubMed | Google Scholar DOI: 10.1128\/CMR.00040-16","DOI":"10.1128\/CMR.00040-16"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lee YM, Tsai WH, You JY, Ing-Tiau Kuo B, Liao PT, Ho CK et al. Parvovirus B19 infection in Taiwanese patients with hematological disorders. J Med Virol. 2003 Dec;71(4):605-9. PubMed | Google Scholar DOI: 10.1002\/jmv.10517","DOI":"10.1002\/jmv.10517"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hanada T, Koike K, Takeya T, Nagasawa T, Matsunaga Y, Takita H. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. Br J Haematol. 1988 Sep;70(1):113-5. PubMed | Google Scholar DOI: 10.1111\/j.1365-2141.1988.tb02442.x","DOI":"10.1111\/j.1365-2141.1988.tb02442.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Subtil D, Garabedian C, Chauvet A. Infection \u00e0 parvovirus B19 et grossesse. Presse Med. 2015 Jun;44(6):647-53. Google Scholar DOI: 10.1016\/j.lpm.2015.04.013","DOI":"10.1016\/j.lpm.2015.04.013"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981 Mar 21;1(8221):664-5. PubMed | Google Scholar DOI: 10.1016\/S0140-6736(81)91579-8","DOI":"10.1016\/S0140-6736(81)91579-8"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Brown KE. Haematological consequences of parvovirus B19 infection. Best Pract Res Clin Haematol. 2000 Jun;13(2):245-59. PubMed | Google Scholar DOI: 10.1053\/beha.1999.0071","DOI":"10.1053\/beha.1999.0071"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Brown KE, Young NS. Parvoviruses and Bone Marrow Failure. Stem Cells. 1996;14(2):151-63. PubMed | Google Scholar DOI: 10.1002\/stem.140151","DOI":"10.1002\/stem.140151"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Karmochkine M. Infection humaine par le parvovirus B19. Mise au point. Rev Med Interne. 1995 Dec 1;16(12):905-12. PubMed | Google Scholar DOI: 10.1016\/0248-8663(96)80811-3","DOI":"10.1016\/0248-8663(96)80811-3"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Prassouli A, Papadakis V, Tsakris A, Stefanaki K, Garoufi A, Haidas S et al. Classic transient erythroblastopenia of childhood with human parvovirus B19 genome detection in the blood and bone marrow. J Pediatr Hematol Oncol. 2005 Jun;27(6):333-6. PubMed | Google Scholar DOI: 10.1097\/01.mph.0000169249.72858.8c","DOI":"10.1097\/01.mph.0000169249.72858.8c"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Cilla N, Domitien L, Arrada N, Chiffre D, Mahe P, Vincent L et al. Transient aplastic crisis triggered by parvovirus B19 in a family with hereditary spherocytosis. IDCases. 2020 Jan 1;21:e00802. PubMed | Google Scholar DOI: 10.1016\/j.idcr.2020.e00802","DOI":"10.1016\/j.idcr.2020.e00802"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Melica G, Scerra S, Leli\u00e8vre JD, Morinet F, Pillet S. Parvovirus B19. EMC - Maladies Infectieuses. 2011;8(3):1-6. DOI: 10.1016\/S1166-8598(11)58122-0","DOI":"10.1016\/S1166-8598(11)58122-0"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Chuhjo T, Nakao S, Matsuda T. Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin. Am J Hematol. 1999 Mar;60(3):222-4. PubMed | Google Scholar DOI: 10.1002\/(SICI)1096-8652(199903)60:3<222::AID-AJH9>3.0.CO;2-K","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<222::AID-AJH9>3.0.CO;2-K"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:10:30Z","timestamp":1792588230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/54\/2\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":17,"URL":"https:\/\/doi.org\/10.11604\/pamj.2026.54.2.49819","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"article-number":"49819"}}